Alternating chemo-radiotherapy with cisplatin and 5-fluorouracil plus bleomycin by continuous infusion for locally advanced undifferentiated carcinoma nasopharyngeal type
Identifieur interne : 000455 ( France/Analysis ); précédent : 000454; suivant : 000456Alternating chemo-radiotherapy with cisplatin and 5-fluorouracil plus bleomycin by continuous infusion for locally advanced undifferentiated carcinoma nasopharyngeal type
Auteurs : N. Azli [Algérie] ; J. P Armand [France] ; M. Rahal [Algérie] ; P. Wibault [France] ; H. Boussen [Tunisie] ; F. Eschwege [France] ; G. Schwaab [France] ; J. Gasmi [France] ; M. Bachouchi [France] ; E. Cvitkovic [France]Source :
- European Journal of Cancer [ 0959-8049 ] ; 1992.
Abstract
More than 80% of undifferentiated carcinoma nasopharyngeal type patients with N3 disease (AJC-UICC 1987) will die with or from distant metastases within 3 years after the first symptom. From February 1986 to November 1987 30 consecutive patients with very advanced local disease were entered in a programme with chemotherapy-radiotherapy (CT-RT) alternation after a thorough work-up to eliminate the possibility of distant metastases. Protocol: two cycles of cisplatin 100 mg/m2 day 1, bleomycin 15 mg intravenously day 1 and 16 mg/m2 per day by continuous infusion days 1–5; 5-fluorouracil (5-FU) 650 mg/m2 per day by continuous infusion days 1–5 4 weeks apart. This was followed by two series of high-energy radiotherapy, 35 Gy/3.5 weeks, with a third chemotherapy cycle in between. 27 men and 3 women were treated, the median age was 37 years (range 17–71) and the mean WHO performance status was 1 (range 0–3). TNM classification: 15 T4, 9 T3, 6 T2, 28 N3 and 2 N2c. 18 patients had nodes larger than 8 cm and 24 had bulky bilateral cervical nodes. Toxicity for this protocol was moderate, nausea and vomiting being the main side-effects. Results after two CT cycles were 3 complete responses (CR; 10%), 22 partial responses (PR; 73%), 2 disease stabilisations, 2 progressions, and 1 patient inevaluable. Of the 30 patients, 27 patients completed the CT-RT protocol, 2 patients died before radiotherapy and 1 refused treatment after 2 days on protocol. 25 patients were in CR 3 months after the end of radiotherapy. As of August 1991, with a median follow-up of 55 months (range 43–63), there are 17 patients alive, 2 of them with active disease and 15 are NED (2 after salvage therapy).
Url:
DOI: 10.1016/0959-8049(92)90005-M
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000599
- to stream Istex, to step Curation: 000293
- to stream Istex, to step Checkpoint: 000B45
- to stream Main, to step Merge: 001387
- to stream Main, to step Curation: 001335
- to stream Main, to step Exploration: 001335
- to stream France, to step Extraction: 000455
Links to Exploration step
ISTEX:3CF1F5540FA63EEE0C128E93727A934BCDF2BD31Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Alternating chemo-radiotherapy with cisplatin and 5-fluorouracil plus bleomycin by continuous infusion for locally advanced undifferentiated carcinoma nasopharyngeal type</title>
<author><name sortKey="Azli, N" sort="Azli, N" uniqKey="Azli N" first="N" last="Azli">N. Azli</name>
</author>
<author><name sortKey="Armand, J P" sort="Armand, J P" uniqKey="Armand J" first="J. P" last="Armand">J. P Armand</name>
</author>
<author><name sortKey="Rahal, M" sort="Rahal, M" uniqKey="Rahal M" first="M" last="Rahal">M. Rahal</name>
</author>
<author><name sortKey="Wibault, P" sort="Wibault, P" uniqKey="Wibault P" first="P" last="Wibault">P. Wibault</name>
</author>
<author><name sortKey="Boussen, H" sort="Boussen, H" uniqKey="Boussen H" first="H" last="Boussen">H. Boussen</name>
</author>
<author><name sortKey="Eschwege, F" sort="Eschwege, F" uniqKey="Eschwege F" first="F" last="Eschwege">F. Eschwege</name>
</author>
<author><name sortKey="Schwaab, G" sort="Schwaab, G" uniqKey="Schwaab G" first="G" last="Schwaab">G. Schwaab</name>
</author>
<author><name sortKey="Gasmi, J" sort="Gasmi, J" uniqKey="Gasmi J" first="J" last="Gasmi">J. Gasmi</name>
</author>
<author><name sortKey="Bachouchi, M" sort="Bachouchi, M" uniqKey="Bachouchi M" first="M" last="Bachouchi">M. Bachouchi</name>
</author>
<author><name sortKey="Cvitkovic, E" sort="Cvitkovic, E" uniqKey="Cvitkovic E" first="E" last="Cvitkovic">E. Cvitkovic</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:3CF1F5540FA63EEE0C128E93727A934BCDF2BD31</idno>
<date when="1992" year="1992">1992</date>
<idno type="doi">10.1016/0959-8049(92)90005-M</idno>
<idno type="url">https://api.istex.fr/document/3CF1F5540FA63EEE0C128E93727A934BCDF2BD31/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000599</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000599</idno>
<idno type="wicri:Area/Istex/Curation">000293</idno>
<idno type="wicri:Area/Istex/Checkpoint">000B45</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000B45</idno>
<idno type="wicri:doubleKey">0959-8049:1992:Azli N:alternating:chemo:radiotherapy</idno>
<idno type="wicri:Area/Main/Merge">001387</idno>
<idno type="wicri:Area/Main/Curation">001335</idno>
<idno type="wicri:Area/Main/Exploration">001335</idno>
<idno type="wicri:Area/France/Extraction">000455</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">Alternating chemo-radiotherapy with cisplatin and 5-fluorouracil plus bleomycin by continuous infusion for locally advanced undifferentiated carcinoma nasopharyngeal type</title>
<author><name sortKey="Azli, N" sort="Azli, N" uniqKey="Azli N" first="N" last="Azli">N. Azli</name>
<affiliation wicri:level="1"><country xml:lang="fr">Algérie</country>
<wicri:regionArea>C.A.C. Benbadis, Constantine</wicri:regionArea>
<wicri:noRegion>Constantine</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Armand, J P" sort="Armand, J P" uniqKey="Armand J" first="J. P" last="Armand">J. P Armand</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Institut Gustave-Roussy, Unite La Grange Villejuif</wicri:regionArea>
<wicri:noRegion>Unite La Grange Villejuif</wicri:noRegion>
<wicri:noRegion>Unite La Grange Villejuif</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Rahal, M" sort="Rahal, M" uniqKey="Rahal M" first="M" last="Rahal">M. Rahal</name>
<affiliation wicri:level="1"><country xml:lang="fr">Algérie</country>
<wicri:regionArea>C.A.C. Benbadis, Constantine</wicri:regionArea>
<wicri:noRegion>Constantine</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wibault, P" sort="Wibault, P" uniqKey="Wibault P" first="P" last="Wibault">P. Wibault</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Institut Gustave-Roussy, Unite La Grange Villejuif</wicri:regionArea>
<wicri:noRegion>Unite La Grange Villejuif</wicri:noRegion>
<wicri:noRegion>Unite La Grange Villejuif</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Boussen, H" sort="Boussen, H" uniqKey="Boussen H" first="H" last="Boussen">H. Boussen</name>
<affiliation wicri:level="3"><country xml:lang="fr">Tunisie</country>
<wicri:regionArea>Institut Salah Azaiz, Tunis</wicri:regionArea>
<placeName><settlement type="city">Tunis</settlement>
<region nuts="2">Gouvernorat de Tunis</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Eschwege, F" sort="Eschwege, F" uniqKey="Eschwege F" first="F" last="Eschwege">F. Eschwege</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Institut Gustave-Roussy, Unite La Grange Villejuif</wicri:regionArea>
<wicri:noRegion>Unite La Grange Villejuif</wicri:noRegion>
<wicri:noRegion>Unite La Grange Villejuif</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Schwaab, G" sort="Schwaab, G" uniqKey="Schwaab G" first="G" last="Schwaab">G. Schwaab</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Institut Gustave-Roussy, Unite La Grange Villejuif</wicri:regionArea>
<wicri:noRegion>Unite La Grange Villejuif</wicri:noRegion>
<wicri:noRegion>Unite La Grange Villejuif</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gasmi, J" sort="Gasmi, J" uniqKey="Gasmi J" first="J" last="Gasmi">J. Gasmi</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Institut Gustave-Roussy, Unite La Grange Villejuif</wicri:regionArea>
<wicri:noRegion>Unite La Grange Villejuif</wicri:noRegion>
<wicri:noRegion>Unite La Grange Villejuif</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bachouchi, M" sort="Bachouchi, M" uniqKey="Bachouchi M" first="M" last="Bachouchi">M. Bachouchi</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Institut Gustave-Roussy, Unite La Grange Villejuif</wicri:regionArea>
<wicri:noRegion>Unite La Grange Villejuif</wicri:noRegion>
<wicri:noRegion>Unite La Grange Villejuif</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cvitkovic, E" sort="Cvitkovic, E" uniqKey="Cvitkovic E" first="E" last="Cvitkovic">E. Cvitkovic</name>
<affiliation></affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Institut Gustave-Roussy, Unite La Grange Villejuif</wicri:regionArea>
<wicri:noRegion>Unite La Grange Villejuif</wicri:noRegion>
<wicri:noRegion>Unite La Grange Villejuif</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">European Journal of Cancer</title>
<title level="j" type="abbrev">EJC</title>
<idno type="ISSN">0959-8049</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1992">1992</date>
<biblScope unit="volume">28</biblScope>
<biblScope unit="issue">11</biblScope>
<biblScope unit="page" from="1792">1792</biblScope>
<biblScope unit="page" to="1797">1797</biblScope>
</imprint>
<idno type="ISSN">0959-8049</idno>
</series>
<idno type="istex">3CF1F5540FA63EEE0C128E93727A934BCDF2BD31</idno>
<idno type="DOI">10.1016/0959-8049(92)90005-M</idno>
<idno type="PII">0959-8049(92)90005-M</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0959-8049</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">More than 80% of undifferentiated carcinoma nasopharyngeal type patients with N3 disease (AJC-UICC 1987) will die with or from distant metastases within 3 years after the first symptom. From February 1986 to November 1987 30 consecutive patients with very advanced local disease were entered in a programme with chemotherapy-radiotherapy (CT-RT) alternation after a thorough work-up to eliminate the possibility of distant metastases. Protocol: two cycles of cisplatin 100 mg/m2 day 1, bleomycin 15 mg intravenously day 1 and 16 mg/m2 per day by continuous infusion days 1–5; 5-fluorouracil (5-FU) 650 mg/m2 per day by continuous infusion days 1–5 4 weeks apart. This was followed by two series of high-energy radiotherapy, 35 Gy/3.5 weeks, with a third chemotherapy cycle in between. 27 men and 3 women were treated, the median age was 37 years (range 17–71) and the mean WHO performance status was 1 (range 0–3). TNM classification: 15 T4, 9 T3, 6 T2, 28 N3 and 2 N2c. 18 patients had nodes larger than 8 cm and 24 had bulky bilateral cervical nodes. Toxicity for this protocol was moderate, nausea and vomiting being the main side-effects. Results after two CT cycles were 3 complete responses (CR; 10%), 22 partial responses (PR; 73%), 2 disease stabilisations, 2 progressions, and 1 patient inevaluable. Of the 30 patients, 27 patients completed the CT-RT protocol, 2 patients died before radiotherapy and 1 refused treatment after 2 days on protocol. 25 patients were in CR 3 months after the end of radiotherapy. As of August 1991, with a median follow-up of 55 months (range 43–63), there are 17 patients alive, 2 of them with active disease and 15 are NED (2 after salvage therapy).</div>
</front>
</TEI>
<affiliations><list><country><li>Algérie</li>
<li>France</li>
<li>Tunisie</li>
</country>
<region><li>Gouvernorat de Tunis</li>
</region>
<settlement><li>Tunis</li>
</settlement>
</list>
<tree><country name="Algérie"><noRegion><name sortKey="Azli, N" sort="Azli, N" uniqKey="Azli N" first="N" last="Azli">N. Azli</name>
</noRegion>
<name sortKey="Rahal, M" sort="Rahal, M" uniqKey="Rahal M" first="M" last="Rahal">M. Rahal</name>
</country>
<country name="France"><noRegion><name sortKey="Armand, J P" sort="Armand, J P" uniqKey="Armand J" first="J. P" last="Armand">J. P Armand</name>
</noRegion>
<name sortKey="Bachouchi, M" sort="Bachouchi, M" uniqKey="Bachouchi M" first="M" last="Bachouchi">M. Bachouchi</name>
<name sortKey="Cvitkovic, E" sort="Cvitkovic, E" uniqKey="Cvitkovic E" first="E" last="Cvitkovic">E. Cvitkovic</name>
<name sortKey="Eschwege, F" sort="Eschwege, F" uniqKey="Eschwege F" first="F" last="Eschwege">F. Eschwege</name>
<name sortKey="Gasmi, J" sort="Gasmi, J" uniqKey="Gasmi J" first="J" last="Gasmi">J. Gasmi</name>
<name sortKey="Schwaab, G" sort="Schwaab, G" uniqKey="Schwaab G" first="G" last="Schwaab">G. Schwaab</name>
<name sortKey="Wibault, P" sort="Wibault, P" uniqKey="Wibault P" first="P" last="Wibault">P. Wibault</name>
</country>
<country name="Tunisie"><region name="Gouvernorat de Tunis"><name sortKey="Boussen, H" sort="Boussen, H" uniqKey="Boussen H" first="H" last="Boussen">H. Boussen</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/CobaltMaghrebV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000455 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000455 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Terre |area= CobaltMaghrebV1 |flux= France |étape= Analysis |type= RBID |clé= ISTEX:3CF1F5540FA63EEE0C128E93727A934BCDF2BD31 |texte= Alternating chemo-radiotherapy with cisplatin and 5-fluorouracil plus bleomycin by continuous infusion for locally advanced undifferentiated carcinoma nasopharyngeal type }}
This area was generated with Dilib version V0.6.32. |